scholarly journals Does Epoetin Beta Still Have a Place in Peginterferon Alpha-2a Plus Ribavirin Treatment Strategies for Chronic Hepatitis C?

2016 ◽  
Vol 36 (3) ◽  
pp. 204-214 ◽  
Author(s):  
Pascal Veillon ◽  
Isabelle Fouchard-Hubert ◽  
Dominique Larrey ◽  
Manh Thông Dao ◽  
Louis D'alteroche ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Treatment Strategies ◽  
Epoetin Beta

scholarly journals PIN38 Guideline Evaluation of Costs Related to Chronic Hepatitis C and Antiviral Treatment Strategies

2011 ◽  
Vol 14 (7) ◽  
pp. A272 ◽  
Author(s):  
J.T. Stahmeyer ◽  
C. Krauth ◽  
M. Abdelfattah ◽  
F. Bert ◽  
S. Rossol
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Antiviral Treatment ◽  
Treatment Strategies

New treatment strategies in non-responder patients with chronic hepatitis C

1999 ◽  
Vol 31 ◽  
pp. 184-188 ◽  
Author(s):  
Solko W. Schalm ◽  
Johannes T. Brouwer ◽  
Frank C. Bekkering ◽  
Tekla G.J. van Rossum
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Treatment Strategies ◽  
New Treatment

Metabolic alterations and chronic hepatitis C: treatment strategies

2011 ◽  
Vol 12 (14) ◽  
pp. 2215-2234 ◽  
Author(s):  
Luigi E Adinolfi ◽  
Luciano Restivo ◽  
Rosa Zampino ◽  
Amedeo Lonardo ◽  
Paola Loria
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Treatment Strategies ◽  
Hepatitis C Treatment ◽  
Metabolic Alterations

Thailand practice guideline for management of chronic hepatitis C 2018

2018 ◽  
Vol 1 (3) ◽  
pp. 50-60
Author(s):  
THASL Committee
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Practice Guideline ◽  
Treatment Strategies ◽  
Antiviral Agent ◽  
Hcv Treatment ◽  
Direct Acting Antiviral ◽  
The North ◽  
Direct Acting

Chronic hepatitis C is one of the important cause of chronic liver diseases leading to cirrhosis and hepatocellular carcinoma worldwide. The prevalence of chronic hepatitis C in Thailand is about 1 - 5% where the prevalence is higher in the north and northeastern. Treatment of chronic hepatitis C has been developed and markedly improved in the last 3 decades. Since the advanced development of direct acting antiviral agent (DAA), treatment of chronic hepatitis C has been much improved not only in the efficacy but also tolerability and safety. IFN-free DAA treatment become a standard therapy in many country including Thailand. Due to fast development of HCV treatment strategies, Thailand Association for the Study of the Liver Disease has recurrently developed practice guideline for management of chronic hepatitis C in order to practically guide and to significantly improve HCV treatment in Thailand. The article reveals the detail of Thailand practice guideline for management of chronic hepatitis C 2018

Sign in / Sign up

Export Citation Format

Share Document